Weight loss drugs linked with increased risk of rare eye-blinding condition, study finds
New Delhi: Popular weight loss drugs have been linked to an uncommon eye-blinding condition, according to a new study. Patients with diabetes or obesity are commonly prescribed weight loss drugs, such as Ozempic or Wegovy, containing the protein semaglutide, which helps manage blood sugar by promoting production of insulin. A team of researchers, led by …